Identification of Human Biomarkers Predictive of Diabetes Remission in Type 2 Diabetes Patient (BARIAKINES)

Trial Parameters

Brief Summary

This study focuses on identifying potentially predictive human circulating adipocyte and muscle biomarkers of diabetes remission after bariatric surgery in obese type 2 diabetic (T2D) subjects.

Eligibility Criteria

Inclusion Criteria: * Obese patients of at least grade 2 (body mass index ≥ 35 kg/m²) * Type 2 diabetics * About to undergo bariatric surgery at the Toulouse University Hospital * Affiliated or beneficiaries of a social security plan. * Having provided a free, informed and written consent, signed Exclusion Criteria: * Type 1 diabetic subjects or Maturity-Onset Diabetes of the Youth. * Pregnant and breastfeeding women. * Vulnerable persons as defined in the Public Health Code: protected adults (guardianship, curators), unable to express their consent.

Related Trials